Lab-Grown Blood Vessels Reveal New Target for Preventing Brain Small Vessel Disease
Scientists create 3D brain vessel models that show how NOTCH3 protein drives vascular damage in hereditary stroke disease.
Summary
Researchers developed 3D lab-grown brain blood vessels using stem cells to study CADASIL, a hereditary disease causing strokes and dementia. The vessels showed how excess NOTCH3 protein damages vascular smooth muscle cells, leading to weakened blood vessels. When scientists blocked NOTCH3 activity with drugs, the vessel damage was reversed. This breakthrough provides a new platform for testing treatments and reveals PDGFRβ as a potential therapeutic target for brain vascular health.
Detailed Summary
Brain small vessel disease is a leading cause of stroke and vascular dementia, but studying it has been challenging due to limited access to living brain tissue. This research addresses that gap by creating the first 3D lab-grown models of brain blood vessels using patient stem cells.
Scientists studied CADASIL, a hereditary brain vessel disease caused by mutations in the NOTCH3 gene. They converted patient skin cells into stem cells, then grew them into blood vessel components including smooth muscle cells and endothelial cells in 3D chip-based systems.
The lab-grown vessels from CADASIL patients showed the same abnormalities seen in actual patient brains: excess NOTCH3 protein accumulation, abnormal cell structure, altered calcium signaling, and increased contractile proteins. Importantly, these disease features only appeared in 3D models, not traditional flat cell cultures, highlighting the importance of recreating natural tissue architecture.
When researchers treated the diseased vessels with drugs that block NOTCH3 processing, the abnormalities were reversed, suggesting a potential therapeutic approach. They also identified PDGFRβ as a key downstream target that correlates with disease severity.
For longevity and brain health, this work is significant because it provides a new way to study and potentially treat cerebrovascular diseases that contribute to cognitive decline and stroke. The ability to test treatments on patient-specific vessel models could accelerate drug development for brain vascular health.
However, this is early-stage research using lab models, and clinical applications remain years away. The findings need validation in animal studies and human trials before translating to treatments.
Key Findings
- 3D brain vessel models revealed disease features invisible in traditional 2D cell cultures
- Blocking NOTCH3 protein processing reversed vascular damage in lab-grown vessels
- PDGFRβ protein levels correlated with disease severity in both models and patient tissue
- Patient stem cell-derived vessels accurately reproduced hereditary brain vessel disease features
Methodology
Researchers created 3D vessel-on-chip models using stem cells from CADASIL patients and healthy controls. They compared primary brain cells with lab-generated cells in both 2D and 3D culture systems, testing drug interventions on vessel function.
Study Limitations
Results are from lab-grown models that may not fully replicate human brain vessel complexity. Clinical translation requires extensive safety testing and validation in living systems before human trials.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.